Limba
|
AT13148 is an oral, ATP-competitive, multi-AGC kinaseinhibitor with IC50of 38 nM/402 nM/50 nM, 8 nM, 3 nM, and 6 nM/4 nM for Akt1/2/3, p70S6K, PKA, and ROCKI/II, respectively. Phase 1.
Price | 2.774,00 RON (preturile sunt fara TVA) |
---|---|
Description |
AT13148 is an oral, ATP-competitive, multi-AGC kinaseinhibitor with IC50of 38 nM/402 nM/50 nM, 8 nM, 3 nM, and 6 nM/4 nM for Akt1/2/3, p70S6K, PKA, and ROCKI/II, respectively. Phase 1. |